Warren Buffett Owns These 5 Dividend Aristocrats. Should You?

Motley Fool2021-04-20

Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

125

Report

Comment（20）

w8w8
·2021-04-21
Steamed
Reply
Like
Report
CK11
·2021-04-21
Coca-cola
Reply
1
Report
Fold Replies
- CK11:
  Wor
  2021-04-21
  Reply
  Report
- KF73:
  Chevron 5% dividend
  2021-04-21
  Reply
  Report
KF73
·2021-04-21
Which one do you like?
Reply
4
Report
Fold Replies
- CK11:
  P&G?
  2021-04-21
  Reply
  Report
MOON88
·2021-04-21
Legend
Reply
1
Report
Grednana
·2021-04-21
Yes!
Reply
Like
Report
DasTrader
·2021-04-21
Yes !!
Reply
2
Report
Fold Replies
- DasTrader:
  Okay
  2021-04-21
  Reply
  Report
- DasTrader:
  Like please abd comment
  2021-04-21
  Reply
  Report
- Venus888:
  done. pls like and comment back. thanks
  2021-04-21
  Reply
  Report
SGpHANtom
·2021-04-21
Looks like he does not fancy growth stocks.
Reply
Like
Report
KSONG
·2021-04-21
Lol
Reply
Like
Report
buckethead
·2021-04-21
No thanks
Reply
2
Report
K74
·2021-04-21
Watching
Reply
1
Report
Unknown934
·2021-04-21
Dinosaur
Reply
4
Report
我i168
·2021-04-21
The thing is Buffet collects dividends and re-invest them, $Berkshire Hathaway(BRK.B)$does not pay dividends,as paying dividends attract 30% tax.
Reply
Like
Report
SyedSalman
·2021-04-21
What is happening today should we go dividend stock?
Reply
Like
Report
JJHou
·2021-04-21
Anything that pays lesser than 5% dpu is not an aristocrat! https://www.laohu8.com/m/news/2128846250?lang=en_us&invite=4Y28B7
Reply
3
Report
Fold Replies
- Unknown934:
  Like olease
  2021-04-21
  Reply
  Report
- 我i168:
  And it is before tax
  2021-04-21
  Reply
  Report
JQJQ
·2021-04-20
When u have money u can have anything u want in this universe
Reply
4
Report
Fold Replies
- KF73:
  [强]
  2021-04-21
  Reply
  Report
- Unknown934:
  Like please
  2021-04-21
  Reply
  Report
mummumtumtum
·2021-04-20
Hmm...do we have the power of holding like BH?
Reply
3
Report
Fold Replies
- Unknown934:
  Like like please
  2021-04-21
  Reply
  Report
- Pengwoo:
  aitebet
  2021-04-20
  Reply
  Report
RontheTrader
·2021-04-20
When you got money, you can invest anything you want.
Reply
5
Report
Fold Replies
- Unknown934:
  Like Please
  2021-04-21
  Reply
  Report
JollyBee
·2021-04-20
To follow? On what basis....
Reply
3
Report
Fold Replies
- Unknown934:
  Like please
  2021-04-21
  Reply
  Report
- March_m:
  Warren buffett brand name
  2021-04-20
  Reply
  Report
SirBahamut
·2021-04-20
Yes!
Reply
2
Report
ElPhoenix
·2021-04-20
Hmmm
Reply
4
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2128846250?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-20 21:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2128846250","market":"us","top_or_hot":-1,"title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","media":"Motley Fool","content":"<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABBV","symbol_name":"艾伯维公司","start_time":0,"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","article_id":"2128846250","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","pubTimestamp":1618926923,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ABBV":"艾伯维公司","KO":"可口可乐","JNJ":"强生","BRK.B":"伯克希尔B","CVX":"雪佛龙","PG":"宝洁","BRK.A":"伯克希尔"},"translate_title":"沃伦•巴菲特拥有这5名股息贵族。你应该吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"BRK.A":0.9,"BRK.B":0.9,"CVX":0.9,"JNJ":0.9,"KO":0.9,"PG":0.9},"content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":378819831,"gmtCreate":1619014928923,"gmtModify":1704718359885,"author":{"id":"3575859183800572","authorId":"3575859183800572","name":"w8w8","avatar":"https://static.tigerbbs.com/1a305fe39d1c227693a64cc331afda1a","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3575859183800572","idStr":"3575859183800572"},"htmlText":"Steamed","listText":"Steamed","text":"Steamed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/378819831","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":378934548,"gmtCreate":1618989438584,"gmtModify":1704717941072,"author":{"id":"3581899057268262","authorId":"3581899057268262","name":"CK11","avatar":"https://static.tigerbbs.com/0923eb4b52245eb1bf4d6c510566f9f5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581899057268262","idStr":"3581899057268262"},"htmlText":"Coca-cola","listText":"Coca-cola","text":"Coca-cola","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/378934548","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4092568,"gmtCreate":1619002159955,"gmtModify":1680784950865,"authorId":3581899057268262,"author":{"id":3581899057268262,"idStr":"3581899057268262","authorId":3581899057268262,"name":"CK11","avatar":"https://static.tigerbbs.com/0923eb4b52245eb1bf4d6c510566f9f5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":378934548,"type":1,"supId":4091369,"prevId":0,"content":"<u>Wor</u>","text":"<u>Wor</u>","html":"<u>Wor</u>"},{"id":4091369,"gmtCreate":1618989521279,"gmtModify":1680784931438,"authorId":3579568649549102,"author":{"id":3579568649549102,"idStr":"3579568649549102","authorId":3579568649549102,"name":"KF73","avatar":"https://static.tigerbbs.com/08cb18d8dbd8d12a776f947554bdb6e6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":378934548,"type":1,"supId":0,"prevId":0,"content":"Chevron 5% dividend","text":"Chevron 5% dividend","html":"Chevron 5% dividend"}],"langContent":"EN"},{"id":378931789,"gmtCreate":1618988811841,"gmtModify":1704717934271,"author":{"id":"3579568649549102","authorId":"3579568649549102","name":"KF73","avatar":"https://static.tigerbbs.com/08cb18d8dbd8d12a776f947554bdb6e6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3579568649549102","idStr":"3579568649549102"},"htmlText":"Which one do you like?&nbsp;","listText":"Which one do you like?&nbsp;","text":"Which one do you like?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/378931789","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4091358,"gmtCreate":1618989336899,"gmtModify":1680784935641,"authorId":3581899057268262,"author":{"id":3581899057268262,"idStr":"3581899057268262","authorId":3581899057268262,"name":"CK11","avatar":"https://static.tigerbbs.com/0923eb4b52245eb1bf4d6c510566f9f5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":378931789,"type":1,"supId":0,"prevId":0,"content":"P&amp;G?","text":"P&amp;G?","html":"P&amp;G?"}],"langContent":"EN"},{"id":378056689,"gmtCreate":1618983528641,"gmtModify":1704717866543,"author":{"id":"3575859659136593","authorId":"3575859659136593","name":"MOON88","avatar":"https://static.tigerbbs.com/f09b0d1b368ce9762e9af5a440d99d98","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3575859659136593","idStr":"3575859659136593"},"htmlText":"Legend&nbsp;","listText":"Legend&nbsp;","text":"Legend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/378056689","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":378009679,"gmtCreate":1618976445391,"gmtModify":1704717766443,"author":{"id":"3571355542071247","authorId":"3571355542071247","name":"Grednana","avatar":"https://static.tigerbbs.com/aff5083a5c5c5db47d53e17857443b44","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571355542071247","idStr":"3571355542071247"},"htmlText":"Yes!","listText":"Yes!","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/378009679","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371439724,"gmtCreate":1618964697468,"gmtModify":1704717522491,"author":{"id":"3578802070336057","authorId":"3578802070336057","name":"DasTrader","avatar":"https://static.tigerbbs.com/7e0e1e0e63b10ad89b2a20f8cab20533","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3578802070336057","idStr":"3578802070336057"},"htmlText":"Yes !!","listText":"Yes !!","text":"Yes !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/371439724","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4090095,"gmtCreate":1618976204762,"gmtModify":1680784913107,"authorId":3578802070336057,"author":{"id":3578802070336057,"idStr":"3578802070336057","authorId":3578802070336057,"name":"DasTrader","avatar":"https://static.tigerbbs.com/7e0e1e0e63b10ad89b2a20f8cab20533","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371439724,"type":1,"supId":4088454,"prevId":0,"content":"Okay","text":"Okay","html":"Okay"},{"id":4088074,"gmtCreate":1618964714127,"gmtModify":1680784886364,"authorId":3578802070336057,"author":{"id":3578802070336057,"idStr":"3578802070336057","authorId":3578802070336057,"name":"DasTrader","avatar":"https://static.tigerbbs.com/7e0e1e0e63b10ad89b2a20f8cab20533","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371439724,"type":1,"supId":0,"prevId":0,"content":"Like please abd comment","text":"Like please abd comment","html":"Like please abd comment"},{"id":4088454,"gmtCreate":1618966267023,"gmtModify":1680784885571,"authorId":3572313172431959,"author":{"id":3572313172431959,"idStr":"3572313172431959","authorId":3572313172431959,"name":"Venus888","avatar":"https://static.tigerbbs.com/2eb10c539f367e4d8f1ae8ddf081bfdf","vip":1,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371439724,"type":1,"supId":0,"prevId":0,"content":"done. pls like and comment back. thanks","text":"done. pls like and comment back. thanks","html":"done. pls like and comment back. thanks"}],"langContent":"EN"},{"id":371495882,"gmtCreate":1618964510246,"gmtModify":1704717518298,"author":{"id":"3554964479320407","authorId":"3554964479320407","name":"SGpHANtom","avatar":"https://static.tigerbbs.com/bb33f070d9bea74315c46e4e5e8cedf8","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3554964479320407","idStr":"3554964479320407"},"htmlText":"Looks like he does not fancy growth stocks.","listText":"Looks like he does not fancy growth stocks.","text":"Looks like he does not fancy growth stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371495882","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371403498,"gmtCreate":1618963818514,"gmtModify":1704717496474,"author":{"id":"3573608981633568","authorId":"3573608981633568","name":"KSONG","avatar":"https://static.tigerbbs.com/0cac42cab0c725d4b65ec3d804892fc9","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3573608981633568","idStr":"3573608981633568"},"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371403498","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371565906,"gmtCreate":1618961749105,"gmtModify":1704717435732,"author":{"id":"3573341177962944","authorId":"3573341177962944","name":"buckethead","avatar":"https://static.tigerbbs.com/fb0baba9e10b75fa4dc0ff143e54bbea","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3573341177962944","idStr":"3573341177962944"},"htmlText":"No thanks&nbsp;","listText":"No thanks&nbsp;","text":"No thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371565906","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371531452,"gmtCreate":1618959845976,"gmtModify":1704717389653,"author":{"id":"3574026189533561","authorId":"3574026189533561","name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574026189533561","idStr":"3574026189533561"},"htmlText":"Watching&nbsp;","listText":"Watching&nbsp;","text":"Watching","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371531452","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371242425,"gmtCreate":1618956598967,"gmtModify":1704717339193,"author":{"id":"3568773327054096","authorId":"3568773327054096","name":"Unknown934","avatar":"https://static.tigerbbs.com/8b3574572ddefc308a01b8cc301667c4","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3568773327054096","idStr":"3568773327054096"},"htmlText":"Dinosaur","listText":"Dinosaur","text":"Dinosaur","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371242425","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371243429,"gmtCreate":1618956207861,"gmtModify":1704717333494,"author":{"id":"3563873670221480","authorId":"3563873670221480","name":"我i168","avatar":"https://static.tigerbbs.com/34b2d0551b5ab028c13ab35747c4df8c","vip":1,"crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3563873670221480","idStr":"3563873670221480"},"htmlText":"The thing is Buffet collects dividends and re-invest them, <a href=\"https://laohu8.com/S/BRK.B\">$Berkshire Hathaway(BRK.B)$</a>does not pay dividends,as paying dividends attract 30% tax.&nbsp;","listText":"The thing is Buffet collects dividends and re-invest them, <a href=\"https://laohu8.com/S/BRK.B\">$Berkshire Hathaway(BRK.B)$</a>does not pay dividends,as paying dividends attract 30% tax.&nbsp;","text":"The thing is Buffet collects dividends and re-invest them, $Berkshire Hathaway(BRK.B)$does not pay dividends,as paying dividends attract 30% tax.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371243429","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371288145,"gmtCreate":1618941243787,"gmtModify":1704717280586,"author":{"id":"3575428511337945","authorId":"3575428511337945","name":"SyedSalman","avatar":"https://static.tigerbbs.com/3098e1613bc596a8c47f41915cbcfe5b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3575428511337945","idStr":"3575428511337945"},"htmlText":"What is happening today should we go dividend stock?","listText":"What is happening today should we go dividend stock?","text":"What is happening today should we go dividend stock?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371288145","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371205051,"gmtCreate":1618935211173,"gmtModify":1704717229196,"author":{"id":"3576571081015553","authorId":"3576571081015553","name":"JJHou","avatar":"https://static.tigerbbs.com/daf1a3da1c7cdab169f93706775fe6e6","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3576571081015553","idStr":"3576571081015553"},"htmlText":"Anything that pays lesser than 5% dpu is not an aristocrat! https://www.laohu8.com/m/news/2128846250?lang=en_us&amp;invite=4Y28B7","listText":"Anything that pays lesser than 5% dpu is not an aristocrat! https://www.laohu8.com/m/news/2128846250?lang=en_us&amp;invite=4Y28B7","text":"Anything that pays lesser than 5% dpu is not an aristocrat! https://www.laohu8.com/m/news/2128846250?lang=en_us&invite=4Y28B7","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/371205051","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4086446,"gmtCreate":1618956612095,"gmtModify":1680784855410,"authorId":3568773327054096,"author":{"id":3568773327054096,"idStr":"3568773327054096","authorId":3568773327054096,"name":"Unknown934","avatar":"https://static.tigerbbs.com/8b3574572ddefc308a01b8cc301667c4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371205051,"type":1,"supId":0,"prevId":0,"content":"Like olease ","text":"Like olease ","html":"Like olease "},{"id":4086396,"gmtCreate":1618956264482,"gmtModify":1680784853414,"authorId":3563873670221480,"author":{"id":3563873670221480,"idStr":"3563873670221480","authorId":3563873670221480,"name":"我i168","avatar":"https://static.tigerbbs.com/34b2d0551b5ab028c13ab35747c4df8c","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.88%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371205051,"type":1,"supId":0,"prevId":0,"content":"And it is before tax","text":"And it is before tax","html":"And it is before tax"}],"langContent":"EN"},{"id":371683601,"gmtCreate":1618931373103,"gmtModify":1704717143196,"author":{"id":"3581929836617050","authorId":"3581929836617050","name":"JQJQ","avatar":"https://community-static.tradeup.com/news/845141bd57e8236ea8f40273531a9ea9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581929836617050","idStr":"3581929836617050"},"htmlText":"When u have money u can have anything u want in this universe","listText":"When u have money u can have anything u want in this universe","text":"When u have money u can have anything u want in this universe","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/371683601","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4086733,"gmtCreate":1618958975572,"gmtModify":1680784860581,"authorId":3579568649549102,"author":{"id":3579568649549102,"idStr":"3579568649549102","authorId":3579568649549102,"name":"KF73","avatar":"https://static.tigerbbs.com/08cb18d8dbd8d12a776f947554bdb6e6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371683601,"type":1,"supId":0,"prevId":0,"content":"[强]","text":"[强]","html":"[强]"},{"id":4086449,"gmtCreate":1618956622250,"gmtModify":1680784856514,"authorId":3568773327054096,"author":{"id":3568773327054096,"idStr":"3568773327054096","authorId":3568773327054096,"name":"Unknown934","avatar":"https://static.tigerbbs.com/8b3574572ddefc308a01b8cc301667c4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371683601,"type":1,"supId":0,"prevId":0,"content":"Like please","text":"Like please","html":"Like please"}],"langContent":"EN"},{"id":371698413,"gmtCreate":1618929959432,"gmtModify":1704717105943,"author":{"id":"3581079319641993","authorId":"3581079319641993","name":"mummumtumtum","avatar":"https://static.tigerbbs.com/1314a5de0c397dde3e609fa1f0de4fba","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581079319641993","idStr":"3581079319641993"},"htmlText":"Hmm...do we have the power of holding like BH?","listText":"Hmm...do we have the power of holding like BH?","text":"Hmm...do we have the power of holding like BH?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/371698413","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4086451,"gmtCreate":1618956628936,"gmtModify":1680784852452,"authorId":3568773327054096,"author":{"id":3568773327054096,"idStr":"3568773327054096","authorId":3568773327054096,"name":"Unknown934","avatar":"https://static.tigerbbs.com/8b3574572ddefc308a01b8cc301667c4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371698413,"type":1,"supId":0,"prevId":0,"content":"Like like please","text":"Like like please","html":"Like like please"},{"id":4084971,"gmtCreate":1618931282016,"gmtModify":1680784838979,"authorId":3580001001481457,"author":{"id":3580001001481457,"idStr":"3580001001481457","authorId":3580001001481457,"name":"Pengwoo","avatar":"https://static.tigerbbs.com/aa79ab2280befd8251905f4287c40ba8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371698413,"type":1,"supId":0,"prevId":0,"content":"aitebet","text":"aitebet","html":"aitebet"}],"langContent":"EN"},{"id":371601693,"gmtCreate":1618929302112,"gmtModify":1704717092470,"author":{"id":"3567752910264104","authorId":"3567752910264104","name":"RontheTrader","avatar":"https://static.tigerbbs.com/00db92015cab1f6a368d98213e5b73a7","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3567752910264104","idStr":"3567752910264104"},"htmlText":"When you got money, you can invest anything you want.","listText":"When you got money, you can invest anything you want.","text":"When you got money, you can invest anything you want.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/371601693","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4086452,"gmtCreate":1618956642458,"gmtModify":1680784854343,"authorId":3568773327054096,"author":{"id":3568773327054096,"idStr":"3568773327054096","authorId":3568773327054096,"name":"Unknown934","avatar":"https://static.tigerbbs.com/8b3574572ddefc308a01b8cc301667c4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371601693,"type":1,"supId":0,"prevId":0,"content":"Like Please","text":"Like Please","html":"Like Please"}],"langContent":"EN"},{"id":371877659,"gmtCreate":1618929065271,"gmtModify":1704717087292,"author":{"id":"3579343091008394","authorId":"3579343091008394","name":"JollyBee","avatar":"https://static.tigerbbs.com/bda177a64ab7e899518f5a76c54348c0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3579343091008394","idStr":"3579343091008394"},"htmlText":"To follow? On what basis....","listText":"To follow? On what basis....","text":"To follow? On what basis....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/371877659","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4086455,"gmtCreate":1618956648513,"gmtModify":1680784854030,"authorId":3568773327054096,"author":{"id":3568773327054096,"idStr":"3568773327054096","authorId":3568773327054096,"name":"Unknown934","avatar":"https://static.tigerbbs.com/8b3574572ddefc308a01b8cc301667c4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371877659,"type":1,"supId":0,"prevId":0,"content":"Like please","text":"Like please","html":"Like please"},{"id":4084629,"gmtCreate":1618929562706,"gmtModify":1680784827279,"authorId":3580437128970359,"author":{"id":3580437128970359,"idStr":"3580437128970359","authorId":3580437128970359,"name":"March_m","avatar":"https://static.tigerbbs.com/c79c26d5f3dd57115bbcf794ff43dff2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":371877659,"type":1,"supId":0,"prevId":0,"content":"Warren buffett brand name ","text":"Warren buffett brand name ","html":"Warren buffett brand name "}],"langContent":"EN"},{"id":371849810,"gmtCreate":1618928350430,"gmtModify":1704717062347,"author":{"id":"3581734227956830","authorId":"3581734227956830","name":"SirBahamut","avatar":"https://community-static.tradeup.com/news/bfb00d5085e2ed1685d99f51539c6bb1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3581734227956830","idStr":"3581734227956830"},"htmlText":"Yes!","listText":"Yes!","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371849810","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":371855149,"gmtCreate":1618928209181,"gmtModify":1704717056686,"author":{"id":"3576293913678893","authorId":"3576293913678893","name":"ElPhoenix","avatar":"https://static.tigerbbs.com/58fb9ba14f694ec9b03d10ee34a5e480","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576293913678893","idStr":"3576293913678893"},"htmlText":"Hmmm&nbsp;","listText":"Hmmm&nbsp;","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/371855149","repostId":2128846250,"repostType":4,"repost":{"id":"2128846250","pubTimestamp":1618926923,"share":"https://ttm.financial/m/news/2128846250?lang=&edition=fundamental","pubTime":"2021-04-20 21:55","market":"us","language":"en","title":"Warren Buffett Owns These 5 Dividend Aristocrats. Should You?","url":"https://stock-news.laohu8.com/highlight/detail?id=2128846250","media":"Motley Fool","summary":"The stock market's dividend yield is at a 10-year low, but these five companies still yield over 2%.","content":"<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, <b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the <b>S&amp;P 500</b> over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.</p>\n<p>Now 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been <b>Apple</b>, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as <b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> and <b><a href=\"https://laohu8.com/S/STNE\">StoneCo</a></b>, which deviate heavily from the way Buffett is known to invest.</p>\n<p>Despite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. They are <b>Coca-Cola</b> (NYSE:KO), <b>Chevron </b>(NYSE:CVX), <b>AbbVie</b> (NYSE:ABBV), <b>Johnson &amp; Johnson</b> (NYSE:JNJ), and <b>Procter &amp; Gamble</b> (NYSE:PG). Here's what to buy and which ones to pass on.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F621924%2Fbuffett-fool.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"453\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Coca-Cola</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $21.47 billion</p>\n<p>Allocation: 7.1%</p>\n<p>Rank: 4/49 securities</p>\n<p>Dividend Yield: 3.1%</p>\n<p>Buffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed.&nbsp;However, the company's performance was on a downtrend even before the pandemic.</p>\n<p><img src=\"https://static.tigerbbs.com/47fb617d5225b2b87be879d1818e7ad9\" tg-width=\"720\" tg-height=\"482\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Revenue (Annual) data by YCharts</p>\n<p>Shifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.</p>\n<h2>2. Chevron</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $4.99 billion</p>\n<p>Allocation: 1.6%</p>\n<p>Rank: 10/49 securities</p>\n<p>Dividend Yield: 5%</p>\n<p>The energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also <a href=\"https://laohu8.com/S/AONE\">one</a> of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and <b>Suncor Energy</b>, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.</p>\n<p>Chevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like <b>ExxonMobil</b>. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.</p>\n<h2>3. AbbVie</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $2.76 billion</p>\n<p>Allocation: 0.9%</p>\n<p>Rank: 15/49 securities</p>\n<p>Dividend Yield: 4.6%</p>\n<p>AbbVie was spun off from <b>Abbott Laboratories</b> in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie <a href=\"https://laohu8.com/S/AONE.U\">one</a> as well.</p>\n<p>Buffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease.&nbsp;Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.</p>\n<h2>4. Johnson &amp; Johnson (J&amp;J)</h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $53.1 million</p>\n<p>Allocation: 0.02%</p>\n<p>Rank: 42/49 securities</p>\n<p>Dividend Yield: 2.5%</p>\n<p>J&amp;J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind <b>Pfizer</b> and <b>Moderna</b>. However, J&amp;J's success doesn't depend on the vaccine. Far from it. J&amp;J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&amp;J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&amp;J a headache, it's got Tylenol and a slew of other brand products to back it up.</p>\n<p>J&amp;J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&amp;J.</p>\n<h2><b>5. Procter &amp; Gamble (P&amp;G)</b></h2>\n<h3>Berkshire Hathaway Portfolio Stats</h3>\n<p>Value: $43.3 million</p>\n<p>Allocation: 0.01%</p>\n<p>Rank: 43/49 securities</p>\n<p>Dividend Yield: 2.3%</p>\n<p>What does P&amp;G have in common with Coke and J&amp;J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&amp;G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&amp;G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020&nbsp;and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&amp;G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&amp;G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&amp;G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&amp;J.</p>\n<h2>A final takeaway</h2>\n<p>With the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&amp;P 500 yields just 1.3%, the lowest level in 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/65e537bf08cd4d6f8d7251c42d963bc0\" tg-width=\"720\" tg-height=\"536\" referrerpolicy=\"no-referrer\"></p>\n<p>KO Dividend Yield data by YCharts</p>\n<p>Despite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Owns These 5 Dividend Aristocrats. Should You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Owns These 5 Dividend Aristocrats. Should You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-20 21:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","CVX":"雪佛龙","BRK.A":"伯克希尔","KO":"可口可乐","BRK.B":"伯克希尔B","PG":"宝洁","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/04/20/warren-buffett-owns-these-5-dividend-aristocrats-s/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2128846250","content_text":"Warren Buffett has spent decades beating the market by focusing on fundamentally sound businesses. The strategy has been a long-term winner. However, Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) actually underperformed the S&P 500 over the last 10 years -- mostly because it didn't own many of the technology stocks that accounted for much of the market's gain.\nNow 90 years old, Buffett knows he'll eventually have to pass the torch to his successors, so he's been trying out some of their ideas. The big winner has been Apple, which now accounts for 38% of Berkshire's portfolio. Berkshire has added other tech stocks as well, such as Snowflake and StoneCo, which deviate heavily from the way Buffett is known to invest.\nDespite these new companies, the vast majority of Berkshire's holdings are in dividend stocks, mostly in the financial and consumer staples sectors. However, only five of the 49 securities that Berkshire holds are Dividend Aristocrats -- members of the S&P 500 that have raised their dividends for at least 25 consecutive years. They are Coca-Cola (NYSE:KO), Chevron (NYSE:CVX), AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), and Procter & Gamble (NYSE:PG). Here's what to buy and which ones to pass on.\nImage source: The Motley Fool.\n1. Coca-Cola\nBerkshire Hathaway Portfolio Stats\nValue: $21.47 billion\nAllocation: 7.1%\nRank: 4/49 securities\nDividend Yield: 3.1%\nBuffett has owned Coca-Cola for what seems like forever, but that doesn't necessarily mean you should go out and buy shares of America's largest beverage company. The pandemic took a toll on Coke's top and bottom line, which is understandable considering many of the restaurants, resorts, and entertainment venues that sell its products were closed. However, the company's performance was on a downtrend even before the pandemic.\n\nKO Revenue (Annual) data by YCharts\nShifting consumer behaviors away from soda toward healthier options paired with limited growth avenues makes Coke's trajectory uncertain. Management is guiding for around $2.15 in 2021 non-GAAP earnings per share (EPS), which would give it a forward P/E ratio around 25. That's not exactly cheap for a slow grower. The only thing really going for Coke is its stable and growing payout. The company is guiding for non-GAAP 2021 free cash flow (FCF) of $8.5 billion, which is more than enough to cover its $7.1 billion in dividend obligations. Coke is likely to continue distributing the majority of its FCF as a dividend payment. But given Coke's valuation and shaky performance, it's best to steer clear unless its price comes down significantly.\n2. Chevron\nBerkshire Hathaway Portfolio Stats\nValue: $4.99 billion\nAllocation: 1.6%\nRank: 10/49 securities\nDividend Yield: 5%\nThe energy sector is full of risky companies and high-yield dividend stocks that are riddled with debt. But it's also one of the best sectors to find value. Buffett is well aware of this opportunity. And although Berkshire owns just two energy stocks, Chevron and Suncor Energy, it also owns 91.1% of Berkshire Hathaway Energy, which has over $100 billion in assets.\nChevron has Buffett written all over it. After an expansion period of high spending and mounting debt, Chevron has spent the last five years decreasing its spending and improving its balance sheet. It has arguably the best balance sheet of the oil majors and can sustain its current oil and gas production without outlaying too much capital. This provides advantages over bulkier majors like ExxonMobil. With WTI oil prices above $60 a barrel, Chevron is well-positioned to have a nice recovery and continue raising its dividend, which currently yields 5%.\n3. AbbVie\nBerkshire Hathaway Portfolio Stats\nValue: $2.76 billion\nAllocation: 0.9%\nRank: 15/49 securities\nDividend Yield: 4.6%\nAbbVie was spun off from Abbott Laboratories in 2013 and has raised its dividend ever since. And because Abbott was a Dividend Aristocrat in 2013 (and continues to be today), that makes AbbVie one as well.\nBuffett has been increasingly looking at the healthcare industry for value and dividends. AbbVie's 4.8% dividend yield and low valuation are right up Buffett's alley. It generated $10.56 billion in 2020 adjusted diluted EPS, giving it an adjusted P/E ratio of just 10. It's also guiding for around $12.42 in adjusted diluted 2021 EPS. The only real danger with AbbVie is its concentrated drug portfolio. 43% of 2020 revenue came from Humira, the leading prescription medicine used to treat Crohn's disease. Humira's revenue is expected to decline in the coming years, so AbbVie is developing new drugs to help offset that revenue loss. AbbVie isn't without its risks, but it seems like a reasonable value right now.\n4. Johnson & Johnson (J&J)\nBerkshire Hathaway Portfolio Stats\nValue: $53.1 million\nAllocation: 0.02%\nRank: 42/49 securities\nDividend Yield: 2.5%\nJ&J made headlines last week after its COVID-19 vaccine was suspended due to reports of severe blood clots. It's the latest hiccup in the company's vaccine rollout, which was already lagging behind Pfizer and Moderna. However, J&J's success doesn't depend on the vaccine. Far from it. J&J is a massive healthcare behemoth that generates sales from three core segments -- pharmaceuticals, medical devices, and consumer goods. This reach gives it diverse revenue streams unlike AbbVie, which is a pure-play pharmaceutical company. J&J has generated steady results throughout market cycles. So, although the vaccine delays may be giving J&J a headache, it's got Tylenol and a slew of other brand products to back it up.\nJ&J is similar to Coca-Cola in that it isn't necessarily cheap, it isn't growing quickly, but it has the size and track record that dividend investors love. Chevron and AbbVie seem better positioned at this time, but it's hard to go wrong with J&J.\n5. Procter & Gamble (P&G)\nBerkshire Hathaway Portfolio Stats\nValue: $43.3 million\nAllocation: 0.01%\nRank: 43/49 securities\nDividend Yield: 2.3%\nWhat does P&G have in common with Coke and J&J? All three companies are the largest U.S.-traded stocks by market cap in their respective industries. And all three have raised their dividends for 57 consecutive years. P&G is the quintessential recession-proof stock. Demand for its products is relatively insulated from market cycles. However, P&G is arguably a better consumer staple investment than Coke. Unlike Coke, it was able to grow revenue and earnings in 2020 and plans on growing its organic sales further to cap off fiscal year 2021 (FY 2021). P&G is also a cheaper stock, trading at a P/E ratio of 26 compared to Coke's 30. And finally, P&G generates nearly twice the FCF needed to cover its dividend. Given its entrenched position and track record for stable low to mid-single-digit growth, P&G is the safest Dividend Aristocrat on this list and arguably a better buy than Coke or J&J.\nA final takeaway\nWith the market at an all-time high, dividend stocks that yield over 3%, let alone 2%, are increasingly harder to come by. The average stock in the S&P 500 yields just 1.3%, the lowest level in 10 years.\n\nKO Dividend Yield data by YCharts\nDespite growth and valuation concerns, each Dividend Aristocrat that Berkshire owns deserves recognition for yielding over 2%. However, inflation is now 2.6%. Investors and retirees looking to generate income that exceeds inflation could consider Chevron or AbbVie.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":125,"commentSize":20,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}